tiprankstipranks
Advertisement
Advertisement

ALNY Stock Latest News

Alnylam: TTR Growth In Line With Expectations Keeps Risk-Reward Balanced and Price Target Unchanged at $370
RatingsAlnylam: TTR Growth In Line With Expectations Keeps Risk-Reward Balanced and Price Target Unchanged at $370
20h ago
ALNY
Alnylam price target lowered to $470 from $510 at H.C. Wainwright
PremiumThe Fly
Alnylam price target lowered to $470 from $510 at H.C. Wainwright
2d ago
ALNY
Alnylam: Buy Rating Reaffirmed as Differentiated RNAi Pipeline and Upcoming Catalysts Support Unchanged $550 Price Target
PremiumRatings
Alnylam: Buy Rating Reaffirmed as Differentiated RNAi Pipeline and Upcoming Catalysts Support Unchanged $550 Price Target
5d ago
ALNY
Komodo expands strategic partnership with Alnylam
PremiumThe Fly
Komodo expands strategic partnership with Alnylam
6d ago
ALNY
Alnylam: Neutral Stance Maintained as TTR-CM Growth Slows and Pipeline Remains Early; $370 Price Target Unchanged
PremiumRatings
Alnylam: Neutral Stance Maintained as TTR-CM Growth Slows and Pipeline Remains Early; $370 Price Target Unchanged
7d ago
ALNY
Analyst Reiterates Buy on Alnylam, Maintains $510 Price Target on Pipeline and Growth Optionality
PremiumRatingsAnalyst Reiterates Buy on Alnylam, Maintains $510 Price Target on Pipeline and Growth Optionality
7d ago
ALNY
Alnylam: Hold Rating Reaffirmed as TTR Franchise Growth Offsets Slight Sales Shortfall; $370 Price Target Unchanged
Premium
Ratings
Alnylam: Hold Rating Reaffirmed as TTR Franchise Growth Offsets Slight Sales Shortfall; $370 Price Target Unchanged
16d ago
ALNY
Alnylam management to meet with Oppenheimer
Premium
The Fly
Alnylam management to meet with Oppenheimer
20d ago
ALNY
Alnylam, GENESIS Pharma expand commercial partnership
PremiumThe Fly
Alnylam, GENESIS Pharma expand commercial partnership
21d ago
ALNY
JPMorgan Says Buy the Dip in These 2 Large-Cap Biotech Stocks
PremiumMarket News
JPMorgan Says Buy the Dip in These 2 Large-Cap Biotech Stocks
27d ago
ALNY
INSM
Alnylam, Inceptive form strategic AI collaboration
PremiumThe Fly
Alnylam, Inceptive form strategic AI collaboration
27d ago
ALNY
Analyst Reiterates Hold Rating and Keeps $370 Price Target Amid Mixed Near‑Term Amvuttra Trends
PremiumRatings
Analyst Reiterates Hold Rating and Keeps $370 Price Target Amid Mixed Near‑Term Amvuttra Trends
1M ago
ALNY
Alnylam Shareholders Reaffirm Board, Pay Practices and Auditor
PremiumCompany AnnouncementsAlnylam Shareholders Reaffirm Board, Pay Practices and Auditor
1M ago
8K
ALNY
StubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
Premium
The Fly
StubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
1M ago
AMT
BAP
Alnylam initiated with a Buy at Citi
Premium
The Fly
Alnylam initiated with a Buy at Citi
1M ago
ALNY
Alnylam’s New Hypertension Combo Study Could Reshape Its Long-Term Value
PremiumCompany Announcements
Alnylam’s New Hypertension Combo Study Could Reshape Its Long-Term Value
2M ago
ALNY
Alnylam Steps Into Obesity Drug Race With New ALN-2232 Trial
PremiumCompany Announcements
Alnylam Steps Into Obesity Drug Race With New ALN-2232 Trial
2M ago
ALNY
Alnylam’s New Phase 1 ALN-4915 Trial: Early Safety Data in Focus for ALNY Investors
PremiumCompany Announcements
Alnylam’s New Phase 1 ALN-4915 Trial: Early Safety Data in Focus for ALNY Investors
2M ago
ALNY
Alnylam’s HMBeacon Trial Adds a New Growth Angle in Women’s Bleeding Disorders
PremiumCompany Announcements
Alnylam’s HMBeacon Trial Adds a New Growth Angle in Women’s Bleeding Disorders
2M ago
ALNY
PLTR, KTOS, ALNY: 3 High P/E Stocks with 40%+ Upside Potential in 2026
PremiumMarket NewsPLTR, KTOS, ALNY: 3 High P/E Stocks with 40%+ Upside Potential in 2026
2M ago
ALNY
KTOS
Alnylam announces new analyses from HELIOS-B study of vutrisiran
Premium
The Fly
Alnylam announces new analyses from HELIOS-B study of vutrisiran
2M ago
ALNY
MBX Biosciences appoints Mark Soued as chief commercial officer.
Premium
The Fly
MBX Biosciences appoints Mark Soued as chief commercial officer.
2M ago
MBX
ALNY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >